<DOC>
	<DOC>NCT02905032</DOC>
	<brief_summary>The objective of this project is to evaluate a treatment decision aid for patients with atrial fibrillation.</brief_summary>
	<brief_title>SDM for Stroke Prevention in Atrial Fibrillation</brief_title>
	<detailed_description>The goal of this study is to determine the extent to which the Anticoagulation Choice tool promotes shared decision making and its impact on anticoagulation use and adherence versus standard care in patients with nonvalvular atrial fibrillation.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Clinician • All clinicians (MDs, NP/PAs, PharmDs) that are responsible for the modality of Anticoagulation in eligible AF patients at participating sites, without exclusion Patient ≥ 18 years of age Chronic nonvalvular atrial fibrillation deemed at high risk of thromboembolic strokes (CHA2D2VASc Score ≥ 1, or 2 in women) Able to read and understand (despite cognitive, sensorial, hearing or language challenges) the informed consent document as determined by the study coordinator during consent Patient • Clinician indicates that patient is not a candidate for a discussion about anticoagulation medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Afib</keyword>
	<keyword>Atrial fib</keyword>
	<keyword>Shared</keyword>
	<keyword>Decision</keyword>
	<keyword>Making</keyword>
	<keyword>Aid</keyword>
	<keyword>AF</keyword>
</DOC>